131 related articles for article (PubMed ID: 30779240)
1. Thyroid cancer clinical trials in the United States: Understanding trends to maximize impact.
Hsieh A; Murchison C; Devaiah A
Head Neck; 2019 Jul; 41(7):2346-2352. PubMed ID: 30779240
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of NIH- and industry-sponsored head and neck cancer clinical trials.
Devaiah A; Murchison C
Laryngoscope; 2016 Sep; 126(9):E300-3. PubMed ID: 27010965
[TBL] [Abstract][Full Text] [Related]
3. Analysis of 473 US Head and Neck Cancer Trials (1996-2014): Trends, Gaps, and Opportunities.
Devaiah A; Murchison C
Otolaryngol Head Neck Surg; 2016 Feb; 154(2):309-14. PubMed ID: 26577773
[TBL] [Abstract][Full Text] [Related]
4. The Current Landscape of Clinical Studies Focusing on Thyroid Cancer: A Comprehensive Analysis of Study Characteristics and Their Publication Status.
Liu Y; Li B; Zheng Q; Xu J; Li J; Lai F; Lin B; Peng S; Lv W; Xiao H
Front Endocrinol (Lausanne); 2020; 11():575799. PubMed ID: 33329384
[TBL] [Abstract][Full Text] [Related]
5. High default rate in thyroid cancer management in Ibadan, Nigeria: a need for health insurance.
Adedapo KS; Fadiji IO; Orunmuyi AT; Ejeh JE; Osifo BO
Afr J Med Med Sci; 2012 Dec; 41 Suppl():105-9. PubMed ID: 23678644
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Impact of the NIH CTSA Program on Clinical Trials Registered With ClinicalTrials.gov.
Berg A
Clin Transl Sci; 2020 Jul; 13(4):818-825. PubMed ID: 32216083
[TBL] [Abstract][Full Text] [Related]
7. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group.
Hölzer S; Reiners C; Mann K; Bamberg M; Rothmund M; Dudeck J; Stewart AK; Hundahl SA
Cancer; 2000 Jul; 89(1):192-201. PubMed ID: 10897018
[TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid cancer.
Caron NR; Clark OH
Curr Treat Options Oncol; 2006 Jul; 7(4):309-19. PubMed ID: 16916491
[TBL] [Abstract][Full Text] [Related]
9. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
10. New treatment modalities in advanced thyroid cancer.
Kapiteijn E; Schneider TC; Morreau H; Gelderblom H; Nortier JWR; Smit JWA
Ann Oncol; 2012 Jan; 23(1):10-18. PubMed ID: 21471561
[TBL] [Abstract][Full Text] [Related]
11. Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Dehbi HM; Mallick U; Wadsley J; Newbold K; Harmer C; Hackshaw A
Lancet Diabetes Endocrinol; 2019 Jan; 7(1):44-51. PubMed ID: 30501974
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Aggressive Thyroid Cancer.
Huang J; Harris EJ; Lorch JH
Surg Pathol Clin; 2019 Dec; 12(4):943-950. PubMed ID: 31672300
[TBL] [Abstract][Full Text] [Related]
13. Investigational therapies for metastatic thyroid carcinoma.
Tuttle RM; Leboeuf R
J Natl Compr Canc Netw; 2007 Jul; 5(6):641-6. PubMed ID: 17623615
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features reclassification and its impact on thyroid malignancy rate and treatment.
Mao ML; Joyal T; Picado O; Kerr D; Lew JI; Farrá JC
J Surg Res; 2018 Oct; 230():47-52. PubMed ID: 30100039
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid cancer.
Kebebew E; Clark OH
Curr Treat Options Oncol; 2000 Oct; 1(4):359-67. PubMed ID: 12057161
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic (undifferentiated) thyroid cancer: improved insight and therapeutic strategy into a highly aggressive disease.
O'Neill JP; O'Neill B; Condron C; Walsh M; Bouchier-Hayes D
J Laryngol Otol; 2005 Aug; 119(8):585-91. PubMed ID: 16102210
[TBL] [Abstract][Full Text] [Related]
17. Impact and outcomes of research sponsored by the American Society for Gastrointestinal Endoscopy.
; Madhoun MF; Cote GA; Ahlawat SK; Ahmad NA; Buscaglia JM; Calderwood AH; Crockett S; Early DS; Gleeson FC; Gurudu SR; Imperiale TF; Liu JJ; Mosler P; Pannala R; Pfau PR; Romagnuolo J; Samadder J; Sethi A; Shergill AK; Shin EJ; Willingham F; Dominitz JA
Gastrointest Endosc; 2016 Sep; 84(3):385-391.e2. PubMed ID: 27349928
[TBL] [Abstract][Full Text] [Related]
18. Review of Pediatric Otolaryngology Clinical Trials: Past Trends and Future Opportunities.
Shetty KR; Komshian SR; Devaiah A; Levi JR
Laryngoscope; 2020 Nov; 130(11):2719-2724. PubMed ID: 31994735
[TBL] [Abstract][Full Text] [Related]
19. Papillary thyroid cancer: medical management and follow-up.
Kloos RT
Curr Treat Options Oncol; 2005 Jul; 6(4):323-38. PubMed ID: 15967085
[TBL] [Abstract][Full Text] [Related]
20. New therapeutic advances in the management of progressive thyroid cancer.
Woyach JA; Shah MH
Endocr Relat Cancer; 2009 Sep; 16(3):715-31. PubMed ID: 19218279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
